BioHarvest Sciences Inc.
BHST
$4.21
-$0.04-0.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.20M | -2.51M | -4.08M | -2.34M | -2.96M |
| Total Depreciation and Amortization | 433.00K | 385.00K | 407.00K | 399.00K | 341.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.05M | 805.00K | 1.87M | 501.00K | 605.00K |
| Change in Net Operating Assets | -1.53M | -768.00K | 343.00K | 11.00K | -379.00K |
| Cash from Operations | -2.25M | -2.09M | -1.46M | -1.43M | -2.39M |
| Capital Expenditure | -654.00K | -425.00K | -592.00K | -684.00K | -393.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.00K | 0.00 | 0.00 | 4.00K | -7.00K |
| Cash from Investing | -668.00K | -425.00K | -592.00K | -680.00K | -400.00K |
| Total Debt Issued | 2.10M | 4.32M | 2.64M | 3.34M | 3.42M |
| Total Debt Repaid | -6.41M | -424.00K | -256.00K | -221.00K | -963.00K |
| Issuance of Common Stock | 19.26M | 5.84M | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.94M | 9.74M | 2.39M | 3.12M | 2.45M |
| Foreign Exchange rate Adjustments | 36.00K | 19.00K | -12.00K | -4.00K | -43.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.06M | 7.24M | 326.00K | 1.01M | -378.00K |